In vivo microdialysis sampling was coupled to capillary liquid chromatography (LC)/electrospray ionization quadrupole ion trap mass spectrometry (MS) to monitor [Met]enkephalin and [Leu]enkephalin in the striatum of anesthetized and freely-moving rats. The LC system utilized a high-pressure pump to load 2.5 µl samples and desalt the 25 µm i.d. by 2 cm long column in 12 min. Samples were eluted with a separate pump at ∼100 nl min −1 . A rapid gradient effectively separated the endogenous neuropeptides in 4 min. A comparison was made for operating the mass spectrometer in the MS 2 and MS 3 modes for detection of the peptides. In standard solutions, the detection limits were similar at 1-2 pM (2-4 amol injected); however, the reproducibility was improved with MS 3 as the relative standard deviation was <5% compared with 20% for MS 2 for 60 pM samples. For dialysate solutions, reconstructed ion chromatograms and tandem mass spectra had much higher signal-to-noise ratios in the MS 3 mode, resulting in more confident detection at in vivo concentrations. The method was successfully used to monitor the peptides under basal conditions and with stimulation of peptide secretion by infusion of elevated K + concentration.
INTRODUCTION
Neurons chemically communicate by releasing neurotransmitters and neuromodulators that interact with receptors on neighboring cells. An important route to understanding brain function is to monitor levels of neurotransmitters in vivo under different behavioral, physiological or pharmacological states. A powerful method of in vivo neurochemical monitoring is microdialysis sampling combined with chemical analysis of collected fractions. In vivo microdialysis has been widely used for monitoring some classes of neurotransmitters including amino acids, catecholamines and indoleamines. 1 -3 This sampling technique has been used much less frequently for neuropeptides even though many neurotransmitters are peptides (at least 100 peptidergic neurotransmitters are known) and they have been implicated in many important functions. 4 A limiting factor in using microdialysis for neuropeptide monitoring is the extremely low concentration of peptides recovered by microdialysis sampling probes. Dialysate concentrations of endogenous peptides usually range from 1 to 100 pM; 5, 6 therefore, even after collecting fractions for 10 min at 1 µl min 1 , only attomole quantities may be available in the entire sample. Hence analytical methods used for neuropeptides in dialysate must have both excellent concentration and mass detection limits. The most common approach to the analysis of neuropeptides is immunoassay, particularly radioimmunoassay (RIA). This method can yield detection limits of 100 amol in microliter fractions, thus achieving adequate sensitivity. 6 While generally considered highly specific, great care must be taken in applying RIA because of the potential for crossreactivity with peptides that contain similar epitopes. 7, 8 Other techniques such as capillary liquid chromatography (LC) with electrochemical detection have been used for peptide analysis of dialysate with some success, although positive identification of compounds at such low levels is problematic with that technique. 9, 10 Advances in capillary LC coupled with tandem mass spectrometry have made this approach highly attractive as a method for determination of peptides in vivo. In this method, samples may be concentrated and desalted on a reversed-phase column. Elution at low flow rates provides Determination of enkephalins by capillary LC-MS 3 efficient electrospray ionization, yielding low attomole detection limits. Successful monitoring of endogenous peptides has been performed using a triple-quadrupole mass spectrometer operated in the single reaction monitoring mode 11, 12 and a quadrupole ion trap (QIT) in the MS 2 mode. 13 Methods that allow full-scan MS n increase confidence in measurement by yielding sequence specific analysis. 14 In principle, further improvements in sensitivity and selectivity may be achieved by utilizing higher stages of mass spectrometry. 15, 16 With each stage of mass spectrometry, both chemical noise and signal decrease; however, chemical noise decreases faster. 17, 18 Therefore, the signal-to-noise ratio (S/N) should increase with higher stages of mass spectrometry as long as electronic noise does not become limiting. 19 While this principle is well known, it has rarely been applied to the determination of trace species. MS 3 has been primarily used in structural characterization or to investigate fragmentation pathways; 20 -22 however, more recently, MS 3 data were utilized to quantitate structural isomeric 23 and isobaric mixtures 24 and various toxins 25, 26 with good reproducibility and improved detection limits. Gas chromatography coupled to MS 3 detection is becoming important in quantitative environmental 27 and drug screening. 28 Improved sensitivity and selectivity make MS 3 31 and secured using cranioplastic cement (Plastics One Inc., Roanoke, VA, USA) and skull screws. Microdialysis probes (CMA Microdialysis) were implanted on the day of experimentation.
For experiments performed on anesthetized rats, animals were initially given an i.p. injection of 400 mg kg 1 chloral hydrate (Sigma) prepared in an isotonic salt solution with 50 mg kg 1 and booster injections given as needed to maintain the surgical plane of anesthesia. Probes were positioned as above and implanted in the striatum at the same coordinates. The probes were perfused for 1 h after implantation prior to data collection.
Microdialysis
Microdialysis probes with 4 mm active length and 20 kDa molecular weight cut-off (CMA/12, CMA Microdialysis) were used for all experiments. The microdialysis probe was connected to the capillary LC system using an ¾50 Following a recording session, the animal was sacrificed and the brain immediately removed and frozen at 80°C until histology was performed. Microdialysis probe placement was verified by visual examination of 30 µm sections taken via cryostat (CM1850, Leika, Bannockburn, IL, USA).
Capillary liquid chromatography-mass spectrometry
In order to prepare an integrated chromatography column-electrospray emitter tip, 32 ¾500 µm long macroporous photopolymer frits were formed within 20 cm lengths of 25 µm i.d. ð 360 o.d. fused-silica capillary in situ 5 cm from the terminus. The polyimide coating on the capillary was removed by rotating the capillary between two metal electrodes through which an electrical arc (7640 V, 60 Hz) was passed until the polyimide was eliminated. An additional 1 cm region of polyimide located ¾4 cm from the ending was removed for laser pulling by burning over a flame. Remaining debris was wiped away using a methanol-moistened Kimwipe (Kimberly-Clark Corporation, Roswell, GA, USA). Capillaries were filled with a polymer solution as described elsewhere. 13, 33 The region to be pulled was concealed from UV light with a 330 µm i.d. PEEK tubing sleeve (Upchurch Scientific, Oak Harbor, WA, USA). The remaining region was exposed to UV radiation (254 nm, Spectroline, Westbury, NY, USA) for 30 min. Capillaries were flushed with acetone then dried with helium gas for 2 min each using an in-house built pressure bomb operated at 500 psi. The capillary was pulled to a fine point using a P-2000 CO 2 laser puller (Sutter Instrument Co., Novato, CA, USA). A two-line program was cycled once (line 1: heat D 300, velocity D 30, delay D 128, pull D 0; line 2: heat D 300, velocity D 30, delay D 128, pull D 125) with the micrometer set at 786.0 for glass pulling. The resulting tip was etched in 50% HF for 40 s then dipped in water to create a ¾3 µm electrospray emitter. A 2 cm length of the capillary was packed using an acetone slurry of reversed-phase particles (5 µm, Alltima C18, Associates Inc., Deerfield, IL, USA) at 200 psi as described elsewhere. 34 Although macroporous photopolymer frits could be batch produced and stored, we found it necessary to pack columns daily in order to alleviate tip breakage and prevent column drying. It was additionally more facile to pack columns daily rather than maintain them The capillary LC system was comprised of a dual pumping system utilizing an elevated pressure (3400 psi) pump (Haskel Inc., Burbank, CA, USA) for sample loading (7 min) while washing (5 min) and a lower pressure (¾600 psi) HPLC pump (MicroPro, Eldex Laboratories, Napa, CA, USA) for separation and elution (4 min) of the peptides. The different pressures allowed for high flow rates for sample loading and column washing while keeping low flow rates (¾100 nl min 1 ) for a more efficient chromatographic separation and increased electrospray ionization efficiency. Two six-port valves (C2, Cheminert, Valco Instruments, Houston, TX, USA) connected the system as shown in Fig. 1 A rapid gradient was utilized for separation. Mobile phase A was composed of 1% acetic acid, 5% methanol in water and mobile phase B consisted of 1% acetic acid in methanol. Sample loading and washing were performed with 1% acetic acid in water. The mobile phase program consisted of an isocratic step (40% B, 1 min), a linear increase to 75% B over 30 s, followed by an isocratic step at 75% B for 1 min. All solutions were filtered weekly with an aluminum oxide filter (0.02 µm, Anodisc 47, Whatman) prior to use.
The chromatography system was coupled to the mass spectrometer (LCQ Deca, ThermoFinnigan, San Jose, CA, USA) using electrospray ionization (ESI). A C1.5 kV potential was applied to a liquid junction downstream of the splittingtee (see Fig. 1 ). The emitter tip was positioned ¾0.5 mm from the heated capillary of the mass spectrometer using a micromanipulator operated in the x, y and z directions as described previously. [Met]enkephalin and [Leu]enkephalin ions were isolated and fragmented using the MS 3 pathways of m/z 574 ! 397 ! 278 C 323 C 380 and 556 ! 397 ! 278 C 323 C 380, respectively. Collision energies were optimized using constant infusion of enkephalins in 50% methanol/1% acetic acid with a flow rate of 100 nl min 1 . The identity of the granddaughter peaks used for quantification was based on a previous study. Fig. 2 ). Detection limits, calculated as the concentration that would generate S/N D 3 in the RIC, were similar for both Fig. 3 ). Although the detection limits were similar, the MS 3 method proved to be significantly more reproducible as the relative standard deviation (RSD) was 5% at 60 pM by MS 3 whereas the same standard gave an RSD of 20% by MS 2 . This difference was maintained at higher concentrations as the RSD was 1% in MS 3 and 5% in MS 2 at 1800 pM (n D 3). Although for standard solutions the detection limits were similar, greater background discrimination was observed when analyzing actual dialysate samples (compare the chromatograms of standards in Fig. 3 with dialysate in Fig. 4 however, the spectral quality degrades at lower concentrations as incomplete fragmentation is observed as compared with higher concentration samples. Peaks are visible at lower concentrations, although unambiguous identification is hampered by partial fragmentation. MS 3 fragmentation spectra were similarly improved over MS 2 spectra for dialysate samples ( (This fragmentation pattern is similar to that reported previously for these peptides. 35 ) Nearly every peak in the MS 3 spectra can be assigned to the peptides, whereas the MS 2 spectra contain an abundance of extraneous ''noise'' peaks that are not correlated with the peptides. These peaks are due to interferences that have not been eliminated through the first level of ion isolation and fragmentation. Thus, for trace level analytes in complex samples, the additional selectivity of MS 3 improves the reproducibility, spectral quality and S/N. The cleaner spectra provided by MS 3 may also be useful for proteomic applications since it is expected that better peptide identification could be obtained by database searching programs such as SEQUEST or Mascot when spectra used for analysis are free of chemical noise.
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RESULTS AND DISCUSSION
Comparison of MS
In vivo monitoring of enkephalins by microdialysis coupled with capillary LC-MS 3
In order to demonstrate the suitability of capillary LC-MS 3 for in vivo monitoring, the method was used to analyze microdialysis samples collected online at 16.5 min intervals under basal conditions and during infusion of 70 mM K C through the probe in both awake, i.e. freely-moving (n D 4 animals), and anesthetized animals (n D 4) (Fig. 6 ). K C infusion stimulation evoked a substantial increase in peptide levels (see Fig. 6 and Table 1) , due, presumably, to depolarization of neurons and subsequent stimulation of exocytosis. Stimulation in awake animals did not cause overt behavioral changes although quantitative analysis of movements was not performed. A second stimulation performed ¾60 min after the first in anesthetized animals also evoked significant release over basal levels but was reduced compared with the first (see Figs 6(A) and 7) . The diminished response may reflect the inability of neurons to replenish peptide stores in the short time allowed between stimulation.
We observed that a lower concentration of K C (30 mM)
infused for comparable times did not evoke any change (n D 4 animals) in peptide levels (see Fig. 7 ). This concentration of K C would generally be considered sufficient to depolarize neurons and cause release of neurotransmitter; however, it is often found in vitro that peptides require more vigorous stimulation (i.e. neuronal depolarization) to be secreted. 36, 37 Therefore, our observations of a higher threshold for stimulated release are consistent with this model of peptide regulation. These results also allow us to evaluate the effect of chloral hydrate anesthesia on the enkephalins. Anesthesia resulted in an increase in both basal and stimulated enkephalin levels except for basal [Leu]enkephalin levels (see Table 1 ). The increase in extracellular enkephalins observed here may participate in the anesthetic properties of chloral hydrate. Our results are seemingly in contrast to previous reports that 38 This difference may be related to the measurement techniques used. Microdialysis provides an index of extracellular concentration, which is a balance of release and degradation, whereas the tissue measurement is an estimate of release with several assumptions including no alterations in degradation rates. Based on these differences, several possible explanations for the discrepancy may be considered including effects of anesthesia on peptide degradation. Further studies would be required to understand better the effect of anesthesia on the enkephalins.
The enkephalins are produced by proteolysis of proenkephalin A, prodynorphin and proopiomelanocortin within neurons. Earlier work showed that the [Met]enkephalin:
[Leu]enkephalin ratio in striatal tissue was 2.3 : 1.
39 -41 Our microdialysis measurements, which detect only extracellular levels, reveal a ratio of 2.2 : 1 to 3.7 : 1 depending on the conditions (see Table 1 ); however, if dialysate levels are corrected for differences in recovery by probes for the peptides (see Experimental) then the ratios are 
Reproducibility and temporal resolution of method for monitoring
Variability for in vivo samples was considerably higher than that observed for similar concentrations of standards. The RSDs for the basal concentration within individual rats (at least three measurements for each rat) were from 6 to 57% for [Met] enkephalin and from 7 to 38% for [Leu] enkephalin with an average of 22 and 29%, respectively. Mean basal levels in different rats had RSDs of ¾35% (see Table 1 ). In contrast, the RSDs of standards at 60 pM were 5%. The intra-rat variability may indicate natural fluctuations in peptide levels on the time-scale of these measurements whereas the variability between rats may indicate fluctuations due to differences in rats, probe placement and anesthesia (for anesthetized animals). From these results, it is concluded that the method has sufficient reproducibility to detect significant changes in levels of the peptides in vivo.
In previous work we performed monitoring experiments on [Met]enkephalin and [Leu]enkephalin by capillary LC-MS 2 but with 30 min separation times, resulting in a total sampling interval of 41 min. 13 In this work, the separation time was reduced from 30 to 4 min by using a steeper gradient, slightly faster flow rates and decreased column re-equilibration time between separations, thus allowing the sampling rate to be improved 2.5-fold. In principle, the sampling rate could be improved to 4 min because the sensitivity was sufficient to detect enkephalins in 2.5 µl of sample while sampling at 0.6 µl min 1 . In the configuration used, most of the sample is shunted to waste because samples were collected online and the complete analysis (loading, rinsing, separation, column equilibration) requires more time than that required to collect sample. Further improvements would require either faster analysis or sample handling that allowed samples to be collected off-line. In preliminary experiments, we have observed that freezing of samples after collection results in substantial loss of sample, therefore off-line analysis will require identification of suitable sample storage conditions.
CONCLUSION
The capillary LC-MS 3 method described here provides detection limits in the low attomole range and is less susceptible to interferences from complex samples than capillary LC-MS 2 . Reproducible MS 3 spectra devoid of extraneous peaks were obtained even at low picomolar concentrations in complex mixtures. The improved background rejection may be of use in proteomic applications and is useful for improving quantification at low levels. The sensitivity achieved for enkephalins is sufficient to allow routine monitoring in dialysates collected in vivo.
